MarginsXMarginsX
Home › Markets › Health Care › CDT

CDT Equity Inc. (CDT)

CDT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.3770
-5.84% on the day
Market cap
$384K
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerCDT on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2022
SEC CIK0001896212

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
0.8 months
$747K cash at June 30, 2026
Share count, 1 year
+51282.3%
2025-08-14 to 2026-08-12 · +3241058.7% over 3 years
Going-concern doubt
Yes
10-Q filed August 12, 2026
Insider net buying, 12 months
-$2.9M
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt regarding the Company's ability to continue as a going concern for at least the next 12 months from the financial statement filing date."
10-Q 2026-08-12
Cash and burn$747K cash; operating cash flow -$2.9M a quarter.Report 2026-06-30
Shares outstanding1,573,340 (2026-08-12); 3,062,025,000 a year earlier; 72,813,776,000 three years earlier. 1y figure adjusted for splits (1-for-2000 overall); 3y figure adjusted for splits (1-for-3000000 overall).Cover page 2026-08-12
Reverse splits, 3 years7; latest 1-for-20 on 2026-11-06Source 2026-11-06
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 1 424B5 takedownsLatest 2026-04-02
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-05-28
AuditorCBIZ CPAs P.C., New York, New York, United States; changed auditors 2 times in 24 months8-K 4.01 2026-06-29
Late filings, 12 months2 NT noticesNT 10-Q 2026-05-15
Insider trades, 12 monthsBought $0, sold $2.9M on the open marketSEC Forms 3/4/5 data sets 2026-09-30
Market cap checkThe listing's market cap implies 1,017,862 shares at the 2026-11-13 price; the latest SEC cover count is 1,573,340 as of 2026-08-12, 1,573,340 after the 1-for-25 and 1-for-20 splits since. The SEC count is the older of the two, so the listing's cap is likely the current one; shares were issued since that cover page.Nasdaq screener and SEC cover page

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$4.6M-$544K$747KNo debt tagsNeeds four quarters10-Q 2026-08-12
Q1 2026
2026-03-31
Not filed-$4.1M-$1.9M$97KNo debt tagsNeeds four quarters10-Q 2026-07-15
Q4 2025
2025-12-31
Not filed-$21.3M-$4.6M$1.5MNo debt tagsNeeds four quarters10-K 2026-04-15
Q3 2025
2025-09-30
Not filed-$7.1M-$4.4M$3.8MNo debt tagsNeeds four quarters10-Q 2025-11-13
Q2 2025
2025-06-30
Not filed-$6.0M-$2.6M$3.3MNo debt tagsNeeds four quarters10-Q 2026-08-12
Q1 2025
2025-03-31
Not filed-$4.8M-$3.9M$2.1MNo debt tagsNeeds four quarters10-Q 2026-07-15
Q4 2024
2024-12-31
Not filed-$2.4M-$3.8M$554K$1.8MNeeds four quarters10-K 2026-04-15
Q3 2024
2024-09-30
Not filed-$6.5M-$2.0M$71K$2.5MNeeds four quarters10-Q 2025-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

The SEC filing list did not load in time for this page. It is on SEC EDGAR and in the full dossier.

Price moves

WindowReturn
1 week-69.5%
1 month-95.6%
3 months-100.0%
Year to date-100.0%
1 year-100.0%
From 52-week high-100.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
CDTTWCDT Equity Inc. Warrant$0.0070

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
LABTLakewood-Amedex Biotherapeutics Inc.$0.2194-22.31%$520K
SPRCSciSparc Ltd.$0.3307-10.62%$815K
OGENOragenics Inc.$0.1980-1.49%$893K
MTNBMatinas Biopharma Holdings Inc.$0.9270+3.00%$908K
GOVXGeoVax Labs Inc.$2.02+18.48%$1.1M
BDRXBiodexa Pharmaceuticals plc American Depositary Shs$2.24-6.28%$1.2M
ELABPMGC Holdings Inc.$1.66+5.06%$1.3M
KAPAKairos Pharma Ltd.$0.4069-10.30%$1.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier